ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "rheumatoid arthritis"

  • Abstract Number: 2235 • ACR Convergence 2024

    The Updated PREVENT (Predicting Risk of CVD EVENTs) Algorithm Is Not Able to Indicate Subclinical Coronary or Carotid Atherosclerosis Better Than the Traditional Pooled Cohort Equations in Rheumatoid Arthritis

    J. Alex B. Gibbons1, Joan Bathon2 and Jon Giles3, 1Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 2Columbia University, NEW YORK, NY, 3Cedars Sinai Medical Center, Los Angeles, CA

    Background/Purpose: Patients with RA are at increased risk of atherosclerotic cardiovascular disease (ASCVD), yet traditional 10-year CVD risk calculators—such as the 2013 Pooled Cohort Equations…
  • Abstract Number: 2252 • ACR Convergence 2024

    Long-term Efficacy of Filgotinib Monotherapy and Combination Therapy: Interim Results from a Post Hoc Analysis of the FINCH 4 Study

    Maya H. Buch1, Patrick Verschueren2, Roberto Caporali3, Thomas Huizinga4, Edmund V. Ekoka Omoruyi5, Dick de Vries6, Jeffrey Ritsema7, Francesco De Leonardis8 and Daniel Aletaha9, 1Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom, 2Department of Rheumatology, University Hospital Leuven and KU Leuven, Leuven, Belgium, 3Department of Clinical Sciences and Community Health, University of Milan, and Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO, Milan, Italy, 4Department of Rheumatology, Leiden University, Leiden, Netherlands, 5Biostatistics, Galapagos NV, Mechelen, Belgium, 6Clinical Development, Galapagos BV, Leiden, Netherlands, 7Medical Affairs, Galapagos BV, Leiden, Netherlands, 8Medical Affairs, Galapagos GmbH, Basel, Switzerland, 9Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Wien, Austria

    Background/Purpose: Filgotinib (FIL) is a preferential Janus kinase 1 inhibitor for the treatment of moderate to severe RA. FINCH 4 (NCT03025308) is an ongoing, open-label,…
  • Abstract Number: 2273 • ACR Convergence 2024

    Time-Trends in Real-World Glucocorticoid Treatment Strategies in Patients with Early Rheumatoid Arthritis: Results from the Canadian Early Arthritis Cohort(CATCH) Study

    Orit Schieir1, Marie-France Valois2, Louis Bessette3, Carter Thorne4, Gilles Boire5, Susan Bartlett2, Glen Hazlewood6, Carol Hitchon7, Diane Tin4, Hugues Allard-Chamard8, Bindee Kuriya9, Janet Pope10 and Vivian Bykerk11, and on behalf of CATCH Investigators., 1McGill University, Montreal, QC, Canada, 2Centre for Outcomes Research & Eval, Montreal, QC, Canada, 3University of Laval, Quebec City, QC, Canada, 4Newmarket Rheumatology Consultants, Newmarket, ON, Canada, 5Retired, Sherbrooke, QC, Canada, 6University of Calgary, Calgary, AB, Canada, 7University of Manitoba, Winnipeg, MB, Canada, 8University of Sherbrooke, Sherbrooke, QC, Canada, 9University of Toronto, Toronto, Canada, 10University of Western Ontario, London, ON, Canada, 11Hospital For Special Surgery, New York, NY

    Background/Purpose: Increased availability of a wider array of effective RA treatments and evidence of glucocorticoid (GC)-related adverse events have prompted updated recommendations limiting GC use…
  • Abstract Number: 2533 • ACR Convergence 2024

    Genome-wide Association of Rheumatoid Arthritis in the African Ancestry Identifies HLA Amino Acid Polymorphisms of Risk

    Harrison Zhang1, Saori Sakaue2, Daniel Posner3, Jing Cui4, Dorris Yang5, Ashley Budu-Aggrey6, Yuk-Lam Ho3, Lauren Costa3, Rachael Matty3, Selena Huang1, Paul Monach7, Kazuyoshi Ishaigaki8, Monika Maripuri7, Connor Melley7, Vidisha Tanukonda7, Rahul Sangar3, Gregory McDermott9, Mary Jeffway1, Vincent Laufer10, Yukinori Okada11, Ian Scott12, S. Louis Bridges13, Kelly Cho3, Chuan Hong14, Jennifer E. Huffman15, Tianxi Cai16, Soumya Raychaudhuri1 and Katherine Liao1, and the VA Million Veteran Program, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Cambridge, MA, 3U.S. Department of Veterans Affairs, Boston, MA, 4Brigham Women's Hospital, Boston, MA, 5Harvard Medical School, Cambridge, MA, 6Bristol Medical School, Manchester, United Kingdom, 7VA Boston Healthcare System, Boston, MA, 8Keio University School of Medicine, Tokyo, Japan, 9Brigham and Women's Hospital, Brookline, MA, 10Michigan Medicine, Birmingham, AL, 11Graduate School of Medicine, the University of Tokyo, Tokyo, Japan, 12School of Medicine, Keele University, Keele, United Kingdom, 13Division of Rheumatology, Weill Cornell Medical College, New York, NY, 14Duke University, Durham, NC, 15VA Boston Healthcare System, Palo Alto, 16Harvard T.H. Chan School of Public Health, Boston, MA

    Background/Purpose: The association between RA and the MHC is largely explained by five amino acid (AA) positions: DRB1 positions 11, 13, 71, and 74, HLA-B…
  • Abstract Number: 2608 • ACR Convergence 2024

    Evolution of Rheumatoid Arthritis Pharmacotherapy: A Ten-Year Analysis of Biologic and Targeted Synthetic DMARD Use and Its Predictors in a National Sample of Rheumatology Practices

    Jing Li1, Gabriela Schmajuk2 and Jinoos Yazdany3, 1University of California, San Francisco, San Francisco, CA, 2UCSF / SFVA, San Francisco, CA, 3UCSF, San Francisco, CA

    Background/Purpose: The last decade has seen dramatic shifts in pharmacotherapy for rheumatoid arthritis (RA) with the increasing availability of biologic and targeted synthetic DMARDs (b/tsDMARDs).…
  • Abstract Number: PP16 • ACR Convergence 2024

    Utilization of My Knee Notes for Enhanced Healthcare Management

    Tien Sydnor-Campbell, Medically Retired, Philadelphia, PA

    Background/Purpose: Living with chronic knee issues for 40 years has been incredibly challenging. My knee pain began as early as 6th grade but got overlooked…
  • Abstract Number: 0037 • ACR Convergence 2024

    Clonal Haematopoiesis of Indeterminate Potential (CHIP) Is Associated with Disease Activity in Rheumatoid Arthritis

    Athena Chin1, Sue Branford2, Annabelle Small3, katie Lowe3, malcolm Smith4, Monika Kutyna5, Robert King2, Susanna Proudman6, Devendra Hiwase7 and Mihir Wechalekar8, 1Royal Adelaide Hospital, Tranmere, South Australia, Australia, 2SA Pathology, Adelaide, Australia, 3Flinders University, Adelaide, Australia, 4Flinders Medical Centre, Adelaide, Australia, 5South Australian Health and Medical Research Institute, Adelaide, Australia, 6Royal Adelaide Hospital and University of Adelaide, Medindie, South Australia, Australia, 7Royal Adelaide Hospital, Adelaide, Australia, 8Flinders Medical Centre, Bedford Park, Australia

    Background/Purpose: Clonal haematopoiesis (CH) of indeterminate potential (CHIP) is defined as the detection of recurrent somatic mutations in genes that are known to drive haematological…
  • Abstract Number: 0054 • ACR Convergence 2024

    Supernatants from Macrophages Stimulated with Citrullinated and MAA-Modified Fibrinogen Contain PDGF-BB and TGF-b and Upregulate Fibrotic Markers in Human Lung Fibroblasts

    Nozima Aripova1, Michael Duryee1, Bryant England1, Carlos Hunter1, Lauren Klingemann1, Nigina Aripova2, Amy Nelson1, Jill Poole1, Dawn Katafiasz1, Kristina Bailey1, Geoffrey Thiele1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2WUSTL, St. Louis, MO

    Background/Purpose: Lung tissues from patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) have greater levels of malondialdehyde-acetaldehyde adducts (MAA) that co-localize with citrullinated (CIT) and…
  • Abstract Number: 0134 • ACR Convergence 2024

    Use of Oral Contraceptives in Females with Rheumatoid Arthritis Is Not Associated with an Increased Risk of Venous Thromboembolism: United Kingdom-population Based Study

    James Galloway1, Victoria Basey2, Anna Barkaway3, Simon de Lusignan4 and Maya H. Buch5, 1Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 2Pfizer UK, Tadworth, United Kingdom, 3Pfizer, Tadworth, United Kingdom, 4Royal College of General Practitioners Research and Surveillance Centre, Oxford, United Kingdom, 5Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

    Background/Purpose: While the use of oral contraceptives in females with immune mediated inflammatory diseases such as rheumatoid arthritis (RA) is acknowledged as a risk factor…
  • Abstract Number: 0214 • ACR Convergence 2024

    Real-World Treatment Patterns of Clinical Practice Guideline Therapies in Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Justin Dunn1, Scott Matson2, Michael George3, Yangyuna Yang1, Punyasha Roul4, Jorge Rojas5, grant Cannon6, Sauer brian7, Jeffrey Curtis8, Joshua Baker3, Ted Mikuls1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Kansas, Kansas City, MO, 3University of Pennsylvania, Philadelphia, PA, 4UNMC, Omaha, NE, 5Seattle VA, Mexico, Mexico, 6University of Utah and Salt Lake City VA, Salt Lake City, UT, 7Salt Lake City VA/University of Utah, Salt Lake City, UT, 8University of Alabama at Birmingham, Hoover, AL

    Background/Purpose: The American College of Rheumatology (ACR) and American College of Chest Physicians (CHEST) recently released clinical practice guidelines for the treatment of RA-interstitial lung…
  • Abstract Number: 0358 • ACR Convergence 2024

    Residual’ Fatigue and Its Severity in Patients with Rheumatoid Arthritis in Clinical Remission: Prevalence and Associated Factors

    Rosa Maria Morlà Novell1, Beatriz Frade-Sosa2, Lola Tobalina Maestre3, Meritxell Sallés Lizarzaburu4, Virginia Ruiz-Esquide2, Maria López Lasanta5, Georgina Salvador Alarcón6, Noemí Busquets Pérez7, Marta Valls Roc8, Enrique Gonzalez Dávila9, Jose Alfredo Gomez-Puerta10 and Raimon Sanmartí Sala10, and ARCat study Group, 1Hospital Clínic de Barcelona, Barcelona, Spain, 2Hospital Clinic de Barcelona, Barcelona, Spain, 3Fundació Clinic per la Recerca clínica, Barcelona, Spain, 4Althaia Xarxa Assistencial Universitària Manresa, Manresa, Catalonia, Spain, 5Hospital Universitari Vall d´Hebron, Rheumatology, Barcelona, Spain, 6Hospital Mútua de Terrassa, Terrassa, Spain, 7HOSP. GENERAL DE GRANOLLERS, GRANOLLERS, Spain, 8Hospital Universitari Josep Trueta, Girona, 9Universidad de La Laguna, Santa Cruz de Tenerife, Spain, 10Rheumatology Department, Hospital Clinic of Barcelona, Barcelona, Spain

    Background/Purpose: Fatigue is a frequent and annoying symptom in rheumatoid arthritis (RA) patients that is often not assessed at routine follow-up visits. Residual’ fatigue has…
  • Abstract Number: 0458 • ACR Convergence 2024

    Long-Term Outcomes in Seronegative Rheumatoid Arthritis

    Bradly Kimbrough1, Cynthia Crowson2, Sara Achenbach3 and Elena Myasoedova2, 1Mayo Clinic Rochester, Rochester, MN, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Rochester, Rochester, MN

    Background/Purpose: Seronegative rheumatoid arthritis (RA) is a heterogenous disease distinct from seropositive RA regarding genetic risk factors, pathobiology, and prognosis. Notably, recent studies have shown…
  • Abstract Number: 0474 • ACR Convergence 2024

    Association Between Rheumatoid Arthritis and Survival After Cancer: A Systematic Literature Review and Meta-analysis

    Joshua Hsieh1, Avneet Kaur2, Hemant Khandelia3, Teresa Jewell4, Aman Singh5, Lauren Barkley6, Ishan Bansal7, Simmi Oberoi8 and Namrata Singh9, 1Lakeside High School, Seattle, WA, 2SUNY Upstate, Buffalo, NY, 3AIIMS, New Delhi, Delhi, India, 4University of Washington, Seattle, WA, 5Rajindra Hospital, Patiala, Punjab, India, 6Brandeis University, Boston, MA, 7Yale University, New Haven, CT, 8Rajindra Hospital, New Delhi, India, 9University of Washington, Bellevue, WA

    Background/Purpose: Increasing evidence suggests that inflammation, a hallmark of rheumatoid arthritis (RA), is associated with an elevated risk of cancer and can influence cancer outcomes.…
  • Abstract Number: 0492 • ACR Convergence 2024

    A Machine Learning Model for the Early Identification of Rheumatoid Arthritis: Development and Validation

    Michael Dreyfuss1, Yonatan Jenudi2, Dan Riesel3, Or Ramni3, Daniel Underberger4, Benjamin Getz5, Shlomit Steinberg-Koch3, Douglas White6 and Elena Myasoedova7, 1Predicta Med, Ramat Gan, Israel, 2[email protected], Ramat Gan, Israel, 3Predicta Med Analytics Ltd., Ramat Gan, Israel, 4Predicta Med Analytics Ltd., Bridgeport, CT, 5CTO, Ramat Gan, Israel, 6Gundersen Health System, Onalaska, WI, 7Mayo Clinic, Rochester, MN

    Background/Purpose: Patients with rheumatoid arthritis often experience clinically significant delays in diagnosis (Sørensen et al., 2015; Raza et al., 2011). RA can present similarly to…
  • Abstract Number: 0508 • ACR Convergence 2024

    Real-World Evidence for GP2015 in Patients with Rheumatoid Arthritis: Safety Outcomes from German Observational Data

    Xenofon Baraliakos1, Cristofer Salvati2, Elena Bachinskaya2, Samriddhi Sinha2 and Klaus Krüger3, 1Rheumazentrum Ruhrgebiet Herne, and Ruhr-University Bochum, Bochum, Germany, 2Medical Affairs, Sandoz Hexal AG, Holzkirchen, Germany, Holzkirchen, Germany, 3Rheumatologisches Praxiszentrum, Munich, Germany, München, Germany

    Background/Purpose: GP2015 is an etanercept biosimilar indicated for the treatment of rheumatoid arthritis (RA).1 The objective of this abstract is to describe the baseline characteristics…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 188
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology